Auranofin Workflows for Redox Cancer Research
2026-08-31
Auranofin gives researchers a controllable way to perturb thioredoxin reductase, connect redox stress with apoptosis, and test radiosensitization in cancer models. This workflow-focused guide shows how to pair the compound with metabolic assays inspired by FOXO3/YAP research while preserving appropriate controls and evidentiary boundaries.
Nanoparticle Uptake by Human Corneal Epithelial Cells
2026-08-31
Azadi and David systematically examined how PLGA nanoparticle size and surface chemistry influence uptake by human corneal epithelial cells. Their in vitro model connects nanoparticle properties with endocytic mechanisms, showing that energy-dependent uptake is dominated by macropinocytosis and caveolae-mediated pathways under the tested conditions.
Dual-Action p38α Inhibitors and Dephosphorylation
2026-08-30
A bioRxiv study shows that selected p38α MAP kinase inhibitors can do more than block catalysis: they can also accelerate WIP1-mediated dephosphorylation by exposing the kinase activation-loop phosphothreonine. This structural and biochemical framework suggests a route to designing inhibitors that combine active-site inhibition with enhanced pathway shutdown, while highlighting the need to test each compound and phosphatase context directly.
Recombinant Human Growth Hormone: Assay Design
2026-08-29
Recombinant Human Growth Hormone research requires more than a proliferation endpoint. This guide translates GH–IGF-1 biology into a layered assay strategy for receptor activation, chondrocyte phenotyping, reagent qualification, and causal mechanism testing.
Foretinib (GSK1363089) Cancer Assay Workflows
2026-08-28
Foretinib (GSK1363089) combines potent Met and VEGFR pathway inhibition with practical utility in proliferation, motility, invasion, and metastasis studies. This workflow pairs tumor cell growth inhibition measurements with direct cell-death and migration readouts to prevent misleading conclusions from single-endpoint assays.
Naftifine HCl in Reliable Cell Assays
2026-08-28
Learn how Naftifine HCl, SKU B1984, can support controlled antifungal and cell-based viability workflows through documented purity, solvent compatibility, and storage guidance. This scenario-driven guide separates established mechanism from assay recommendations and highlights controls needed for interpretable cytotoxicity data.
Crizotinib Hydrochloride in Gastric Assembloids
2026-08-28
Use Crizotinib hydrochloride as a pathway-resolved perturbation tool in matched gastric tumor organoids and stromal assembloids. Comparing monoculture and tumor–stroma responses can reveal whether ALK, c-Met, or ROS1-linked signaling remains drug-sensitive in a more physiologically relevant model.
Probenecid Workflows for MDR and Neuroprotection
2026-08-27
Probenecid gives researchers a reversible way to interrogate MRP-mediated drug efflux, pannexin-1 activity, and injury-associated glial responses in the same experimental program. This guide converts those mechanisms into practical leukemia, transporter, and cerebral ischemia/reperfusion workflows with formulation controls and troubleshooting checkpoints.
Adipose-Neural Axis in Cardiac Arrhythmia
2026-08-27
Fan et al. developed a stem cell-based coculture model showing how epicardial adipose tissue can communicate with sympathetic neurons and cardiomyocytes through a leptin–NPY/Y1R pathway. The study connects this signaling axis to NCX and CaMKII activity, while patient observations support its relevance to atrial fibrillation and identify several experimentally testable intervention points.
Caffeic Acid Phenethyl Ester in NF-κB Assays
2026-08-26
Caffeic Acid Phenethyl Ester (CAPE) provides a practical way to isolate NF-κB signaling in inflammatory, neurodegeneration, and tumor biology workflows. This guide translates its mechanism into dose-response assays, zebrafish experiments, anti-angiogenesis studies, and troubleshooting strategies while keeping pathway interpretation experimentally disciplined.
PCMT1 and Ovarian Cancer Metastasis: CRISPR Screen
2026-08-26
Zhang et al. used a genome-wide CRISPR/Cas9 knockout screen to identify PCMT1 as a driver of anoikis resistance and ovarian cancer dissemination. The study connects extracellular PCMT1 to LAMB3-dependent integrin–FAK–Src signaling, providing a mechanistic framework for understanding how tumor cells interact with the metastatic extracellular matrix.
EZ Cap™ Human PTEN mRNA: Applied Workflows
2026-08-25
Learn how to use EZ Cap™ Human PTEN mRNA in controlled transfection, pathway-rescue, viability, and nanoparticle-delivery studies. Practical handling parameters and troubleshooting guidance help connect PTEN restoration with cancer research and localized gene therapy research.
v-Agatoxin-IVA and Neuronal Ca Channel Diversity
2026-08-24
Sidach and Mintz showed that v-Agatoxin-IVA is not exclusively a high-affinity P-type calcium channel blocker: at micromolar exposure, it also produces incomplete, voltage-dependent blockade of neuronal N-type currents. The study refines pharmacological classification of P-, Q-, and N-type channels and cautions against interpreting toxin sensitivity as an absolute marker of channel identity.
Tetracycline: From Ribosomes to Translational Strategy
2026-08-24
Tetracycline is more than a routine antibiotic selection marker: its reversible engagement of the bacterial 30S ribosomal subunit creates a controllable system for studying protein synthesis, bacterial membrane integrity disruption, and experimental reproducibility. This thought-leadership perspective connects that mechanistic discipline with translational lessons from LKB1–telomerase research while clearly defining the boundaries between bacterial tools and oncology evidence.
Sulfaphenazole Restores Vasodilation in Diabetic Mice
2026-08-23
The reference study identified CYP 2C-derived oxidative stress as a pharmacologically modifiable contributor to endothelial dysfunction in db/db diabetic mice. Sulfaphenazole restored acetylcholine-mediated vasodilation, reduced plasma 8-isoprostane, and increased nitrite without lowering plasma glucose, supporting a vascular mechanism linked to improved nitric oxide bioavailability.
479 records 8/32 page Previous Next First page 上5页 678910 下5页 Last page